Project Grant R01HL182937
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $151,092 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through July 31, 2030. This five-year research initiative focuses on investigating macrophage polarization and function in graft-versus-host disease (GVHD), a major complication of allogeneic hematopoietic stem cell transplantation...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Wisconsin–Madison a Project Grant totaling $639,822 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 15, 2025, with a completion date of June 30, 2029. This research project investigates the role of neutral sphingomyelinase (NSMase), a membrane enzyme involved in sphingolipid metabolism, in cardiac mechanosensing and signal transduction. The research...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $675,405 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2026, with completion targeted for April 30, 2030. This research grant funds a mechanistic investigation into regulatory T cell (Treg) reconstitution during graft versus host disease (GVHD), a major complication of allogeneic hematopoietic stem cell...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of California, San Diego a Project Grant totaling $1,072,936 under the Cardiovascular Diseases Research program (CFDA 93.837) with an award date of September 15, 2025, and a completion deadline of June 30, 2029. The grant funds research into protein aggregation mechanisms in hematopoietic stem cells (HSCs), with the primary deliverable being fundamental scientific discoveries...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Medical College of Wisconsin, Inc. a Project Grant totaling $1,221,260 under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, with completion targeted for May 31, 2030. The research project, titled "Post-Transcriptional Regulation of Vascular Homeostasis by RNA-Binding Proteins," focuses on identifying and characterizing key regulators of vascular...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Wisconsin-Madison a Project Grant of $151,040 under the Cardiovascular Diseases Research program (CFDA 93.837) on February 5, 2026, with completion targeted for August 31, 2026. This fellowship training award supports research investigating the assembly and localization of human ether-à-go-go-related gene (hERG) channel cotranslational complexes in cardiac tissue. The project aims to...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $747,262 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 1, 2026, and scheduled for completion February 28, 2030. This award supports research aimed at defining the multi-omics landscape of phospholamban-induced dilated cardiomyopathy (DCM) to advance precision medicine approaches. The project utilizes top-down...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $776,511 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for May 31, 2029. This award supports research to develop and validate a three-dimensional engineered hemogenic vascular niche model designed to elucidate the microenvironmental factors that promote hematopoietic stem...
- Federal Grant Award Summary Boston University Medical Campus received a $100,228 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 30, 2026, with a completion date of June 30, 2029. The grant funds research investigating the mechanisms of a conserved niche endothelial program that directs hematopoietic stem cell (HSC) migration into the bone marrow. The research aims to identify the...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Wisconsin–Madison a $1.45 million Project Grant on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a five-year research initiative concluding May 31, 2031. The award supports mechanistic research into sex-specific cerebrovascular dysfunction in metabolic syndrome, with the primary objective of identifying subclinical changes in cerebral blood...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $521,101 Project Grant to the University of Wisconsin-Madison on June 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) with a completion date of February 28, 2031. This grant supports research investigating the role of macrophages and hematopoietic stem cell (HSC) trogocytosis in the bone marrow niche. The research focuses on understanding how HSCs acquire macrophage-associated markers through trogocytosis—a rapid membrane protein transfer mechanism—and how this process affects HSC retention in the bone marrow and subsequent homing to the bone marrow niche following transplantation. The project delivers basic research findings aimed at elucidating the mechanistic interactions between bone marrow-resident macrophages and HSCs, with specific focus on characterizing the molecular transfer mechanisms involved in HSC trogocytosis, identifying what membrane-bound proteins and retention machinery are transferred, and determining whether macrophages guide HSC homing through transfer-dependent or independent pathways. These research outcomes will advance understanding of hematopoietic stem cell transplantation biology, with potential implications for improving the efficacy of HSC-based therapies for hematologic malignancies and other blood disorders.Federal Project Grant Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $521.1k | 6/18/26 |